These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7605797)

  • 1. The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes.
    Mobley PW; Lee HF; Curtain CC; Kirkpatrick A; Waring AJ; Gordon LM
    Biochim Biophys Acta; 1995 Jun; 1271(2-3):304-14. PubMed ID: 7605797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-perturbing domains of HIV type 1 glycoprotein 41.
    Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs.
    Mobley PW; Waring AJ; Sherman MA; Gordon LM
    Biochim Biophys Acta; 1999 Apr; 1418(1):1-18. PubMed ID: 10209206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane perturbing actions of HIV type 1 glycoprotein 41 domains are inhibited by helical C-peptides.
    Mobley PW; Barry JA; Waring AJ; Sherman MA; Gordon LM
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):224-42. PubMed ID: 17331029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirals that target the amino-terminal domain of HIV type 1 glycoprotein 41.
    Gordon LM; Waring AJ; Curtain CC; Kirkpatrick A; Leung C; Faull K; Mobley PW
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):677-86. PubMed ID: 7576927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
    Gordon LM; Curtain CC; Zhong YC; Kirkpatrick A; Mobley PW; Waring AJ
    Biochim Biophys Acta; 1992 Aug; 1139(4):257-74. PubMed ID: 1355364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
    Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
    Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
    Pritsker M; Jones P; Blumenthal R; Shai Y
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide.
    Sánchez-Martín MJ; Urbán P; Pujol M; Haro I; Alsina MA; Busquets MA
    Chemphyschem; 2011 Oct; 12(15):2816-22. PubMed ID: 21905195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytes.
    Mobley PW; Curtain CC; Kirkpatrick A; Rostamkhani M; Waring AJ; Gordon LM
    Biochim Biophys Acta; 1992 Aug; 1139(4):251-6. PubMed ID: 1355363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Lee W; Eskandari S; Kaznessis YN; Sherman MA; Waring AJ
    Protein Sci; 2004 Apr; 13(4):1012-30. PubMed ID: 15044732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
    Zheng B; Wang K; Lu L; Yu F; Cheng M; Jiang S; Liu K; Cai L
    AIDS; 2014 Jun; 28(9):1251-60. PubMed ID: 24625369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
    Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
    J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
    Jiang X; Jia Q; Lu L; Yu F; Zheng J; Shi W; Cai L; Jiang S; Liu K
    Amino Acids; 2016 Dec; 48(12):2867-2873. PubMed ID: 27631437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.
    Maddox MW; Longo ML
    Biophys J; 2002 Dec; 83(6):3088-96. PubMed ID: 12496080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane structure of the human immunodeficiency virus gp41 fusion peptide by molecular dynamics simulation. II. The glycine mutants.
    Wong TC
    Biochim Biophys Acta; 2003 Jan; 1609(1):45-54. PubMed ID: 12507757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
    Slepushkin VA; Andreev SM; Sidorova MV; Melikyan GB; Grigoriev VB; Chumakov VM; Grinfeldt AE; Manukyan RA; Karamov EV
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):9-18. PubMed ID: 1736943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.